Royal Bank of Canada
SCMP

Royal Bank of Canada’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Royal Bank of Canada’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,619
Closed -$154K – 7217
2017
Q4 		$154K Sell
8,619
-25,411
-75% -$313K ﹤0.01% 4568
2017
Q3 		$402K Sell
34,030
-47,577
-58% -$534K ﹤0.01% 3979
2017
Q2 		$856K Sell
81,607
-16,669
-17% -$170K ﹤0.01% 3229
2017
Q1 		$1.08M Buy
98,276
+47,089
+92% +$547K ﹤0.01% 3033
2016
Q4 		$694K Buy
51,187
+311
+0.6% +$4.34K ﹤0.01% 3464
2016
Q3 		$626K Sell
50,876
-5,895
-10% -$69.5K ﹤0.01% 3525
2016
Q2 		$623K Buy
56,771
+10,357
+22% +$116K ﹤0.01% 3515
2016
Q1 		$507K Buy
46,414
+26,687
+135% +$337K ﹤0.01% 3628
2015
Q4 		$341K Buy
19,727
+19,250
+4,036% +$345K ﹤0.01% 4119
2015
Q3 		$10K Sell
477
-1,002
-68% -$23K ﹤0.01% 5907
2015
Q2 		$24K Buy
1,479
+979
+196% +$17K ﹤0.01% 5618
2015
Q1 		$8K Buy
+500
New +$7.75K ﹤0.01% 5643
2013
Q4 		– Sell
-76
Closed – – 6309
2013
Q3 		$0 Sell
76
-2,259
-97% -$14.1K ﹤0.01% 6379
2013
Q2 		$15K Buy
+2,335
New +$18.5K ﹤0.01% 5143

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Royal Bank of Canada's SCMP Position: Q1 2018 in Review

Royal Bank of Canada sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 8,619 shares — an estimated $154K sold.

Royal Bank of Canada first reported a position in SCMP in Q2 2013 and held it in 14 quarters. The position peaked at $1.08M in Q1 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Royal Bank of Canada reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 8,619 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $154K.
  • Royal Bank of Canada first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • Royal Bank of Canada's Sucampo Pharmaceuticals, Inc. position peaked at $1.08M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Royal Bank of Canada's 13F filing for Q1 2018, filed 15 May 2018.